Skip to main content
SpringerLink
Log in

When and How to Treat Hypercholesterolemia in the Elderly?

  • Chapter
Book cover Recent Advances in Geriatrics

  • 76 Accesses

Abstract

The utility of lowering serum cholesterol in elderly patients has been questioned for a long time and is still a matter of debate (1). The main question concerns the role of hypercholesterolemia in elderly people, whether it represents at this age a risk factor for coronary heart disease (CHD) and myocardial infarction (MI) as in young people. A quite common opinion holds that the risk associated with total cholesterol “shows a definite waning effect with little impact after age 65” (2) and that “total cholesterol levels...are not considered important risk factors (in elderly patients) (3).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kaiser FE, Morley JE. Cholesterol can be lowered in older persons. Should we care? J Am Geriatric Soc 1990; 38:84–85.

    CAS  Google Scholar 

  2. Kannel WB, Gordon T. Cardiovascular risk factors in the aged: The Framingham Study. In: Haynes SG, Feinleib M. eds. Proceedings of the Second Conference on the Epidemiology of Aging. Bethesda, Maryland: National Institute of Health; 1977:65-89.

    Google Scholar 

  3. Moser M. The management of cardiovascular disease in the elderly. J Am Geriat Soc 1982; 30(suppl):SS20–S29.

    Google Scholar 

  4. Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease: the Framingham Study. Ann Intern Med 1971, 74:1–12.

    Article  PubMed  CAS  Google Scholar 

  5. Multiple Risk-Factor Intervention Trial: risk factor changes and mortality results. JAMA 1982, 248:1465-1477.

    Google Scholar 

  6. Dayton S, Pearce ML, Hasimoto S, Dixon WJ, Tomiyasu U. A controlled clinical trial of a diet high in un-saturated fat in preventing complications of atherosclerosis. Circulation 1969; 39 and 40(suppl II): 1–63.

    Google Scholar 

  7. Castelli WP, Garrison RI, Wilson PWF, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 1986, 256:2835–2838.

    Article  PubMed  CAS  Google Scholar 

  8. Benfante R, Deed D: Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? JAMA 1990, 263: 393–396.

    Article  PubMed  CAS  Google Scholar 

  9. Harris T, Cook EF, Kannel WB, Goldman L. Proportional hazard analysis of risk factors for coronary heart disease in individuals aged 65 or older. J Am Geriatr Soc 1988, 36: 1025–1028.

    Google Scholar 

  10. Rubin SM, Sidney S, Black DM, Browner WS, Hulley SB, Cummings SR. High blood cholesterol in elderly men and the excess risk for coronary heart disease. Ann Intern Med 1990; 113, 916–920.

    Article  PubMed  CAS  Google Scholar 

  11. Corti MC, Guralnik JM, Salive ME, Harris T, Field TS, Wallace RB, Berkman LF, Seeman TE, Glyn RJ, Hennekens CH, Havlik RJ. HDL Cholesterol Predicts Coronary Heart Disease in Older People. JAMA 1995; 274:539–544.

    Article  PubMed  CAS  Google Scholar 

  12. Forette B, Tortrat D, Wolmark Y. Cholesterol as risk factor for mortality in elderly women. Lancet 1989; 1:868–870.

    Article  PubMed  CAS  Google Scholar 

  13. Agner E, Hansen PF. Fasting serum cholesterol and triglycerides in a ten-year prospective study in old age. Acta Med Scand 1983; 214:33–61.

    Article  PubMed  CAS  Google Scholar 

  14. Rudman JD, Mattson DE, Nagraj HS, Caindec N, Rudman IW, Jackson DL. Antecedents of death in the men of a Veteran Administration nursing home. J Am Geriatr Soc 1987; 35:496–502.

    PubMed  CAS  Google Scholar 

  15. Morley JE. Nutritional status of the elderly. Am J Med 1986; 81:679–695.

    Article  PubMed  CAS  Google Scholar 

  16. Isles CA, Hole DJ, Gillis CR, et al. Plasma cholesterol, coronary heart disease and cancer in the Renfrew and Paisley survey. Br Med J 1989; 298:920–924.

    Article  CAS  Google Scholar 

  17. The Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344:1383-1389.

    Google Scholar 

  18. Scandinavian Simvastatin Survival Study Group. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S). Lancet 1995; 345:1274–1275.

    Google Scholar 

  19. Johannesson M, Jonsson B, Kjekshus J, Olsson AG, Pedersen TR, Wedel H, for the Scandinavian Simvastatin Survival Study Group. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. N Engl J Med 1997; 336:332–336.

    Article  PubMed  CAS  Google Scholar 

  20. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutheford JD, Cole TG, Brown L, Warnica W, Arnold MO, Wun CC, Davis BR, Braunwald E, for the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335:1001–1009.

    Article  PubMed  CAS  Google Scholar 

  21. Byington RP, Jukema JW, Salonen JT, et al. Reduction in cardiovascular events during pravastatin therapy: pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. Circulation 1995; 92:2419–2425.

    Article  PubMed  CAS  Google Scholar 

  22. Herd JA, Ballantyne CM, Farmer JA, Ferguson JJ, Gould KL, Jones PH, West MS, Gotto AM Jr. The effect of fluvastatin on coronary atherosclerosis: the lipoprotein and coronary atherosclerosis study (LCAS). 69th Scientific Session of the Americam Heart Association, New Orleans, November 11–13, 1996. Abstract book p. 1-597, n.3496.

    Google Scholar 

  23. Herd JA, West MS, Ballantyne CM, Farmer JA, Ferlic LL, Jonas PH, Gotto AM. Clinical cardiac and all fatal events in the lipoprotein and coronary atherosclerosis study (LCAS). 4th International Symposium on Multiple Risk Factors in Cardiovascular Disease, Washington, April 23–25, 1997. Abstract book, p.76.

    Google Scholar 

  24. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, Mckillop JH, Packard CJ, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333:1301–1307.

    Article  PubMed  CAS  Google Scholar 

  25. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung A, Vekshten VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risks factors for coronary artery disease. Circulation 1990; 81:491–498.

    Article  PubMed  CAS  Google Scholar 

  26. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332:481–487.

    Article  PubMed  CAS  Google Scholar 

  27. Haq IU, Jackson PR, Yeo WW, Ramsay LE. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. Lancet, 1995; 346:1467–1471.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gerontology, Faculty of Medicine, University of Bari, Policlinico, 70124, Bari, Italy

    Antonio Capurso & Sabrina A. Capurso

Authors
  1. Antonio Capurso
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sabrina A. Capurso
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Palermo, Palermo, Italy

    Mario Barbagallo  & Giuseppe Licata  & 

  2. School of Medicine, Wayne State University, Detroit, Michigan, USA

    James R. Sowers

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Capurso, A., Capurso, S.A. (1998). When and How to Treat Hypercholesterolemia in the Elderly?. In: Barbagallo, M., Licata, G., Sowers, J.R. (eds) Recent Advances in Geriatrics. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1483-5_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-1483-5_24

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-1485-9

  • Online ISBN: 978-1-4899-1483-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation